Skip to main content
PMC home page
British Journal of Pharmacology and Chemotherapy logoLink to British Journal of Pharmacology and Chemotherapy
. 1964 Oct;23(2):330–350. doi: 10.1111/j.1476-5381.1964.tb01590.x

A comparison of imipramine, chlorpromazine and related drugs in various tests involving autonomic functions and antagonism of reserpine

G Halliwell, R M Quinton, Frances E Williams
PMCID: PMC1704096  PMID: 14228134

Abstract

Seven structurally-related compounds consisting of three antidepressant drugs (imipramine, desmethylimipramine and amitriptyline), three tranquillizing agents (promazine, chlorpromazine and chlorprothixene) and a hybrid, desmethylpromazine, have been examined in a series of tests involving autonomic functions and antagonism of reserpine. Activities of the compounds in antagonizing reserpine-induced ptosis in rabbits and prolongation of alcohol hypnosis in mice give good correlation with their clinical actions, whilst their activities in augmenting excitation of rats by amphetamine and yohimbine toxicity in mice, and in reversing reserpine-induced bradycardia in rats offer further evidence for drug-induced sensitization to adrenergic or tryptaminic mechanisms, which is not however specific for antidepressant agents. No evidence has been obtained to indicate that a central parasympatholytic action is an important component of the antidepressant activity of imipramine and related drugs.

Full text

PDF
334

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ASKEW B. M. A SIMPLE SCREENING PROCEDURE FOR IMIPRAMINE-LIKE ANTIDEPRESSANT AGENTS. Life Sci. 1963 Oct;10:725–730. doi: 10.1016/0024-3205(63)90076-6. [DOI] [PubMed] [Google Scholar]
  2. AXELROD J., HERTTING G., POTTER L. Effect of drugs on the uptake and release of 3H-norepinephrine in the rat heart. Nature. 1962 Apr 21;194:297–297. doi: 10.1038/194297a0. [DOI] [PubMed] [Google Scholar]
  3. AXELROD J., INSCOE J. K. THE UPTAKE AND BINDING OF CIRCULATING SEROTONIN AND THE EFFECT OF DRUGS. J Pharmacol Exp Ther. 1963 Aug;141:161–165. [PubMed] [Google Scholar]
  4. AXELROD J., WHITBY L. G., HERTTING G. Effect of psychotropic drugs on the uptake of H3-norepinephrine by tissues. Science. 1961 Feb 10;133(3450):383–384. doi: 10.1126/science.133.3450.383. [DOI] [PubMed] [Google Scholar]
  5. BHAGAT B., SHIDEMAN F. E. REPLETION OF CARDIAC CATECHOLAMINES IN THE RAT: IMPORTANCE OF THE ADRENAL MEDULLA AND SYNTHESIS FROM PRECURSORS. J Pharmacol Exp Ther. 1964 Jan;143:77–81. [PubMed] [Google Scholar]
  6. BICKEL M. H., SULSER F., BRODIE B. B. Conversion of transquilizers to antidepressants by removal of one N-methyl group. Life Sci. 1963 Apr;4:247–253. doi: 10.1016/0024-3205(63)90005-5. [DOI] [PubMed] [Google Scholar]
  7. BIEL J. H., NUHFER P. A., HOYA W. K., LEISER H. A., ABOOD L. G. Cholinergic blockade as an approach to the development of new psychotropic agents. Ann N Y Acad Sci. 1962 Jan 13;96:251–262. doi: 10.1111/j.1749-6632.1962.tb50120.x. [DOI] [PubMed] [Google Scholar]
  8. BOBO C. G., DELGA J., JAULMES C. Métabolisme de l'alcool chez les animaux soumis a l'hibernation artificielle. C R Seances Soc Biol Fil. 1956 Nov 18;150(6):1094–1097. [PubMed] [Google Scholar]
  9. BRODIE B. B., BICKEL M. H., SULSER F. Desmethylimipramine, a new type of antidepressant drug. Med Exp Int J Exp Med. 1961;5:454–458. doi: 10.1159/000135120. [DOI] [PubMed] [Google Scholar]
  10. BRODIE B., DICK P., KIELHOLZ P., POELDINGER W., THEOBALD W. Preliminary pharmacological and clinical results with desmethylimipramine (DMI) G 35020, a metabolite of imipramine. Psychopharmacologia. 1961 Dec 19;2:467–474. doi: 10.1007/BF00407446. [DOI] [PubMed] [Google Scholar]
  11. BURN J. H., HOBBS R. A test for tranquillizing drugs. Arch Int Pharmacodyn Ther. 1958 Jan 1;113(3-4):290–295. [PubMed] [Google Scholar]
  12. COSTA E., GARATTINI S., VALZELLI L. Interactions between reserpine, chlorpromazine, and imipramine. Experientia. 1960 Oct 15;16:461–463. doi: 10.1007/BF02171155. [DOI] [PubMed] [Google Scholar]
  13. COSTA E., GESSA G. L., HIRSCH C., KUNTZMAN R., BRODIE B. B. On current status of serotonin as a brain neurohormone and in action of reserpinelike drugs. Ann N Y Acad Sci. 1962 Jan 13;96:118–133. doi: 10.1111/j.1749-6632.1962.tb50107.x. [DOI] [PubMed] [Google Scholar]
  14. COSTA E., PSCHEIDT G. R. Correlations between active eyelid closure and depletion of brain biogenic amines by respine. Proc Soc Exp Biol Med. 1961 Apr;106:693–696. doi: 10.3181/00379727-106-26445. [DOI] [PubMed] [Google Scholar]
  15. DOMENJOZ R., THEOBALD W. [On the pharmacology of tofranil (N-(3-dimethylaminopropyl)-iminodibenzyl hydrochloride]. Arch Int Pharmacodyn Ther. 1959 Jul 1;120:450–489. [PubMed] [Google Scholar]
  16. FROMMEL E., FLEURY C. [On the differential pharmaco-dynamics of tofranil and chlorpromazine. Analgesia, tests with coramine, cardiazol, electroshock benzedrine and their association with meprobamate. Second report]. Med Exp Int J Exp Med. 1959;1:264–268. [PubMed] [Google Scholar]
  17. GARATTINI S., GIACHETTI A., JORI A., PIERI L., VALZELLI L. Effect of imipramine, amitriptyline and their monomethyl derivatives on reserpine activity. J Pharm Pharmacol. 1962 Aug;14:509–514. doi: 10.1111/j.2042-7158.1962.tb11130.x. [DOI] [PubMed] [Google Scholar]
  18. GARATTINI S., GIACHETTI A., PIERI L., RE R. Antagonists of reserpine induced eyelid ptosis. Med Exp Int J Exp Med. 1960;3:315–320. doi: 10.1159/000134971. [DOI] [PubMed] [Google Scholar]
  19. GILES H. M. IMIPRAMINE POISONING IN CHILDHOOD. Br Med J. 1963 Oct 5;2(5361):844–846. doi: 10.1136/bmj.2.5361.844. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. HERR F., STEWART J., CHAREST M. P. Tranquilizers and antidepressants: a pharmacological comparison. Arch Int Pharmacodyn Ther. 1961 Dec 1;134:328–342. [PubMed] [Google Scholar]
  21. JANSSEN P. A., NIEMEGEERS C. J., JAGENEAU A. H. Apomorphine-antagonism in rats. Arzneimittelforschung. 1960 Dec;10:1003–1005. [PubMed] [Google Scholar]
  22. LEE W. C., SHIDEMAN F. E. Role of myocardial catecholamines in cardiac contractility. Science. 1959 Apr 10;129(3354):967–968. doi: 10.1126/science.129.3354.967. [DOI] [PubMed] [Google Scholar]
  23. LESSIN A. W., PARKES M. W. The relation between sedation and body temperature in the mouse. Br J Pharmacol Chemother. 1957 Jun;12(2):245–250. doi: 10.1111/j.1476-5381.1957.tb00128.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. MARSHALL E. F., STIRLING G. S., TAIT A. C., TODRICK A. The effect of iproniazid and imipramine on the blood platelet 5-hydroxytrptamine level in man. Br J Pharmacol Chemother. 1960 Mar;15:35–41. doi: 10.1111/j.1476-5381.1960.tb01207.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. MARTIN W. R., RIEHL J. L., UNNA K. R. Chlorpromazine. III. The effects of chlorpromazine and chlorpromazine sulfoxide on vascular responses to L-epinephrine and levarterenol. J Pharmacol Exp Ther. 1960 Sep;130:37–45. [PubMed] [Google Scholar]
  26. MAXWELL D. R., PALMER H. T. Demonstration of anti-depressant or stimulant properties of imipramine in experimental animals. Nature. 1961 Jul 1;191:84–85. doi: 10.1038/191084a0. [DOI] [PubMed] [Google Scholar]
  27. METYSOVA J., METYS J., VOTAVA Z. PHARMAKOLOGISCHE EIGENSCHAFTEN EINIGER NEUEN TRANQUILIZERS UND ANTIDEPRESSIVEM SUBSTANZEN. Arch Int Pharmacodyn Ther. 1963 Aug 2;144:481–513. [PubMed] [Google Scholar]
  28. MONRO A. M., QUINTON R. M., WRIGLEY T. I. SOME ANALOGS OF IMIPRAMINE. J Med Chem. 1963 May;6:255–261. doi: 10.1021/jm00339a009. [DOI] [PubMed] [Google Scholar]
  29. PELLMONT B., STEINER F. A., BESENDORF H., BAECHTOLD H. P., LAEUPPI E. [On the pharmacology of "taractan", a neuroleptic with special peculiarity of action]. Helv Physiol Pharmacol Acta. 1960;18:241–258. [PubMed] [Google Scholar]
  30. PFEIFFER C. C., JENNEY E. H. The inhibition of the conditioned response and the counteraction of schizophrenia by muscarinic stimulation of the brain. Ann N Y Acad Sci. 1957 Mar 14;66(3):753–764. doi: 10.1111/j.1749-6632.1957.tb40764.x. [DOI] [PubMed] [Google Scholar]
  31. QUINTON R. M., HALLIWELL G. EFFECTS OF ALPHA-METHYL DOPA AND DOPA ON THE AMPHETAMINE EXCITATORY RESPONSE IN RESERPINIZED RATS. Nature. 1963 Oct 12;200:178–179. doi: 10.1038/200178a0. [DOI] [PubMed] [Google Scholar]
  32. QUINTON R. M. THE INCREASE IN THE TOXICITY OF YOHIMBINE INDUCED BY IMIPRAMINE AND OTHER DRUGS IN MICE. Br J Pharmacol Chemother. 1963 Aug;21:51–66. doi: 10.1111/j.1476-5381.1963.tb01501.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. QUINTON R. M. The mydriatic response of mice to atropine. J Pharm Pharmacol. 1963 Apr;15:239–250. doi: 10.1111/j.2042-7158.1963.tb12781.x. [DOI] [PubMed] [Google Scholar]
  34. RAMACHANDRAN B. V., AGREN G. THE RETARDING EFFECT OF ATROPINE ON THE ABSORPTION OF SUBCUTANEOUSLY INJECTED DF32P IN THE RAT. Life Sci. 1963 Nov;11:820–824. doi: 10.1016/0024-3205(63)90092-4. [DOI] [PubMed] [Google Scholar]
  35. SULSER F., WATTS J., BRODIE B. B. On the mechanism of antidepressant action of imipraminelike drugs. Ann N Y Acad Sci. 1962 Jan 13;96:279–288. doi: 10.1111/j.1749-6632.1962.tb50122.x. [DOI] [PubMed] [Google Scholar]
  36. Stein L., Seifter J. Possible Mode of Antidepressive Action of Imipramine. Science. 1961 Jul 28;134(3474):286–287. doi: 10.1126/science.134.3474.286. [DOI] [PubMed] [Google Scholar]
  37. TRIPOD J., BEIN H. J., MEIER R. Characterization of central effects of serpasil (reserpin, a new alkaloid of Rauwolfia serpentina B.) and of their antagonistic reactions. Arch Int Pharmacodyn Ther. 1954 Jan;96(3-4):406–425. [PubMed] [Google Scholar]
  38. VANE J. R., COLLIER H. O., CORNE S. J., MARLEY E., BRADLEY P. B. Tryptamine receptors in the central nervous system. Nature. 1961 Sep 9;191:1068–1069. doi: 10.1038/1911068a0. [DOI] [PubMed] [Google Scholar]
  39. VERNIER V. G. The pharmacology of antidepressant agents. Dis Nerv Syst. 1961 May;22(5):7–13. [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology and Chemotherapy are provided here courtesy of The British Pharmacological Society

RESOURCES